UPDATE: Stephens Starts Castle Biosciences (CSTL) at Overweight
Tweet Send to a Friend
(Updated - January 7, 2022 8:50 AM EST)
Stephens analyst Mason Carrico initiates coverage on Castle Biosciences (NASDAQ: CSTL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stephens analyst Mason Carrico initiates coverage on Castle Biosciences (NASDAQ: CSTL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
